Cited by 6,552Cardiac pacing and defibrillation studiesHeart Failure Treatment and ManagementCardiac Health and Mental Health

The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.

Amiodarone or an Implantable Cardioverter–Defibrillator for Congestive Heart Failure

Open access

Bardy, Gust H., Lee, Kerry L., Mark, Daniel B., Poole, Jeanne E., Packer, Douglas L., Boineau, Robin, Domanski, Michael, Troutman, Charles, Anderson, Jill, Johnson, George, McNulty, Steven E., Clapp-Channing, Nancy, Davidson-Ray, Linda D., Fraulo, Elizabeth S., Fishbein, Daniel P., Luceri, Richard M., Ip, John H.·2005·New England Journal of Medicine

DOI 10.1056/nejmoa043399

Open this paper in CoChat — free account Open PDF

Abstract

BACKGROUND: Sudden death from cardiac causes remains a leading cause of death among patients with congestive heart failure (CHF). Treatment with amiodarone or an implantable cardioverter-defibrillator (ICD) has been proposed to improve the prognosis in such patients. METHODS: We randomly assigned 2521 patients with New York Heart Association (NYHA) class II or III CHF and a left ventricular ejection fraction (LVEF) of 35 percent or less to conventional therapy for CHF plus placebo (847 patients), conventional therapy plus amiodarone (845 patients), or conventional therapy plus a conservatively programmed, shock-only, single-lead ICD (829 patients). Placebo and amiodarone were administered in a double-blind fashion. The primary end point was death from any cause. RESULTS: The median LVEF in patients was 25 percent; 70 percent were in NYHA class II, and 30 percent were in class III CHF. The cause of CHF was ischemic in 52 percent and nonischemic in 48 percent. The median follow-up was 45.5 months. There were 244 deaths (29 percent) in the placebo group, 240 (28 percent) in the amiodarone group, and 182 (22 percent) in the ICD group. As compared with placebo, amiodarone was associated with a similar risk of death (hazard ratio, 1.06; 97.5 percent confidence interval, 0.86 to 1.30; P=0.53) and ICD therapy was associated with a decreased risk of death of 23 percent (0.77; 97.5 percent confidence interval, 0.62 to 0.96; P=0.007) and an absolute decrease in mortality of 7.2 percentage points after five years in the overall population. Results did not vary according to either ischemic or nonischemic causes of CHF, but they did vary according to the NYHA class. CONCLUSIONS: In patients with NYHA class II or III CHF and LVEF of 35 percent or less, amiodarone has no favorable effect on survival, whereas single-lead, shock-only ICD therapy reduces overall mortality by 23 percent.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1056/nejmoa043399

Cites

21 of 21 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1992) · Springer series in statistics · doi:10.1007/978-1-4612-4380-9_25 · Cited by 45,239
Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
The Statistical Analysis of Failure Time Data.
Aitkin, M. A., Kalbfleisch, J. D., & Prentice, R. L. (1981) · Biometrics · doi:10.2307/2530581 · Cited by 9,875
Prophylactic Implantation of a Defibrillator in Patients with Myocardial Infarction and Reduced Ejection Fraction
Moss, A. J., Zaręba, W., Hall, W. J., Klein, H., Wilber, D. J., Cannom, D. S., Daubert, J. P., Higgins, S. L., Brown, M. W., & Andrews, M. L. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013474 · Cited by 6,885
Improved Survival with an Implanted Defibrillator in Patients with Coronary Disease at High Risk for Ventricular Arrhythmia
Moss, A. J., Hall, W. J., Cannom, D. S., Daubert, J. P., Higgins, S. L., Klein, H., Levine, J. H., Saksena, S., Waldo, A. L., Wilber, D., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199612263352601 · Cited by 4,165
A Multiple Testing Procedure for Clinical Trials
O'Brien, P. C., & Fleming, T. R. (1979) · Biometrics · doi:10.2307/2530245 · Cited by 3,311
A Comparison of Antiarrhythmic-Drug Therapy with Implantable Defibrillators in Patients Resuscitated from Near-Fatal Ventricular Arrhythmias
The AVID Investigators (1997) · New England Journal of Medicine · doi:10.1056/nejm199711273372202 · Cited by 3,221
The Statistical Analysis of Failure Time Data
Kalbfleisch, J. D., & Prentice, R. L. (2002) · Wiley Series in Probability and Statistics · doi:10.1002/9781118032985 · Cited by 3,219
Discrete sequential boundaries for clinical trials
GORDON LAN, K. K., & DEMETS, D. L. (1983) · Biometrika · doi:10.1093/biomet/70.3.659 · Cited by 2,310

Flagged first, then by citations

Show all 20 references

Research works printed but not linked: 1

10.2307/2281868 · DOI · Paper page

Sorted by citations

Items 601–700 of 1,019

Incidence, Treatment Intensity, and Incremental Annual Expenditures for Patients Experiencing a Cardiac Implantable Electronic Device Infection
Sohail, M. R., Eby, E. L., Ryan, M. P., Gunnarsson, C., Wright, L. A., & Greenspon, A. J. (2016) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.116.003929 · Cited by 101
Implantable Cardioverter-Defibrillator Registry Risk Score Models for Acute Procedural Complications or Death After Implantable Cardioverter-Defibrillator Implantation
Haines, D. E., Wang, Y., & Curtis, J. P. (2011) · Circulation · doi:10.1161/circulationaha.110.959676 · Cited by 100
Stroke or Transient Ischemic Attack in Patients With Transvenous Pacemaker or Defibrillator and Echocardiographically Detected Patent Foramen Ovale
DeSimone, C. V., Friedman, P. A., Noheria, A., Patel, N. A., DeSimone, D. C., Bdeir, S., Aakre, C. A., Vaidya, V. R., Slusser, J. P., Hodge, D. O., et al. (2013) · Circulation · doi:10.1161/circulationaha.113.003540 · Cited by 100
Withdrawing Implantable Defibrillator Shock Therapy in Terminally Ill Patients
Lewis, W. R., Luebke, D. L., Johnson, N. J., Harrington, M., Costantini, O., & Aulisio, M. P. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.01.017 · Cited by 100
Amiodarone for the treatment and prevention of ventricular fibrillation and ventricular tachycardia
Dorian (2010) · Vascular Health and Risk Management · doi:10.2147/vhrm.s6611 · Cited by 101
Implantable cardioverter defibrillators for primary prevention of death in left ventricular dysfunction with and without ischaemic heart disease: a meta-analysis of 8567 patients in the 11 trials
Shun-Shin, M. J., Zheng, S. L., Cole, G. D., Howard, J. P., Whinnett, Z. I., & Francis, D. P. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx028 · Cited by 100
Primary Prevention Implantable Cardioverter Defibrillators in Patients With Nonischemic Cardiomyopathy
Al‐Khatib, S. M., Fonarow, G. C., Joglar, J. A., Inoue, L. Y. T., Mark, D. B., Lee, K. L., Kadish, A. H., Bardy, G. H., & Sanders, G. D. (2017) · JAMA Cardiology · doi:10.1001/jamacardio.2017.0630 · Cited by 100
Self-citation
European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on risk assessment in cardiac arrhythmias: use the right tool for the right outcome, in the right population
Nielsen, J. C., Lin, Y., Figueiredo, M. J. D. O., Shamloo, A. S., Alfie, A., Bovéda, S., Dagres, N., Toro, D. D., Eckhardt, L. L., Ellenbogen, K. A., et al. (2020) · Journal of Arrhythmia · doi:10.1002/joa3.12338 · Cited by 106
Increased incidence of subacute lead perforation noted with one implantable cardioverter-defibrillator
Danik, S. B., MANSOUR, M. C., Singh, J. P., Reddy, V. Y., Ellinor, P. T., Milan, D. J., Heist, E. K., d’Ávila, A., Ruskin, J. N., & Mela, T. (2007) · Heart Rhythm · doi:10.1016/j.hrthm.2006.12.044 · Cited by 100
Use of a discrimination algorithm to reduce inappropriate shocks with a subcutaneous implantable cardioverter-defibrillator
Gold, M. R., Weiss, R., Theuns, D. A. M. J., Smith, W., León, A. R., Knight, B. P., Carter, N., Husby, M. P., & Burke, M. C. (2014) · Heart Rhythm · doi:10.1016/j.hrthm.2014.04.012 · Cited by 99
Survival After Implantable Cardioverter-Defibrillator Implantation in the Elderly
Yung, D., BIRNIE, D. H., Dorian, P., Healey, J. S., Simpson, C. S., Crystal, E., Krahn, A. D., Khaykin, Y., CAMERON, D. A., Chen, Z., et al. (2013) · Circulation · doi:10.1161/circulationaha.113.001442 · Cited by 99
Device-related complications in subcutaneous versus transvenous ICD: a secondary analysis of the PRAETORIAN trial
Knops, R. E., Pepplinkhuizen, S., Delnoy, P. P. H. M., Boersma, L. V. A., Kuschyk, J., El‐Chami, M. F., Bonnemeier, H., Behr, E. R., Brouwer, T. F., Kääb, S., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac496 · Cited by 99
How many patients fulfil the surface electrocardiogram criteria for subcutaneous implantable cardioverter-defibrillator implantation?
Randles, D. A., Hawkins, N. M., Shaw, M., Patwala, A., Pettit, S., & Wright, D. J. (2013) · EP Europace · doi:10.1093/europace/eut370 · Cited by 98
Traditional and New Composite Endpoints in Heart Failure Clinical Trials: Facilitating Comprehensive Efficacy Assessments and Improving Trial Efficiency
Anker, S. D., Schroeder, S., Atar, D., Bax, J. J., Ceconi, C., Cowie, M., Crisp, A., Dominjon, F., Ford, I., Ghofrani, H. A., et al. (2016) · European Journal of Heart Failure · doi:10.1002/ejhf.516 · Cited by 108
Predictors and Clinical Impact of Late Ventricular Arrhythmias in Patients With Continuous-Flow Left Ventricular Assist Devices
Galand, V., Flecher, E. M., Auffret, V., Boulé, S., Vincentelli, A., Dambrin, C., Mondoly, P., Sacher, F., Nubret, K., Kindo, M. J., et al. (2018) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2018.05.006 · Cited by 98
Outcomes of Implantable Cardioverter-Defibrillator Use in Patients With Comorbidities
Steinberg, B. A., Al‐Khatib, S. M., Edwards, R., Han, J., Bardy, G. H., Bigger, J. T., Buxton, A. E., Moss, A. J., Lee, K. L., Steinman, R. C., et al. (2014) · JACC Heart Failure · doi:10.1016/j.jchf.2014.06.007 · Cited by 98
Self-citation
European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on risk assessment in cardiac arrhythmias: use the right tool for the right outcome, in the right population
Nielsen, J. C., Lin, Y.-J., de Oliveira Figueiredo, M. J., Sepehri Shamloo, A., Alfie, A., Boveda, S., Dagres, N., Di Toro, D., Eckhardt, L. L., Ellenbogen, K., et al. (2020) · EP Europace · doi:10.1093/europace/euaa065 · Cited by 98
Survival of Patients Receiving a Primary Prevention Implantable Cardioverter-Defibrillator in Clinical Practice vs Clinical Trials
Al‐Khatib, S. M., Hellkamp, A. S., Bardy, G. H., Hammill, S. C., Hall, W. J., Mark, D. B., Anstrom, K. J., Curtis, J. P., Al‐Khalidi, H. R., Curtis, L. H., et al. (2013) · JAMA · doi:10.1001/jama.2012.157182 · Cited by 97
Self-citation
Long-Term Survival of Patients With Heart Failure and Ventricular Conduction Delay Treated With Cardiac Resynchronization Therapy
Auricchio, A., Metra, M., Gasparini, M., Lamp, B., Klersy, C., Curnis, A., Fantoni, C., Gronda, E., & Vogt, J. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2006.07.087 · Cited by 97
Sudden cardiac death after myocardial infarction in patients with type 2 diabetes
Junttila, J. M., Barthel, P., Myerburg, R. J., Mäkikallio, T. H., Bauer, A., Ulm, K., Kiviniemi, A. M., Tulppo, M. P., Perkiömäki, J. S., Schmidt, G. P., et al. (2010) · Heart Rhythm · doi:10.1016/j.hrthm.2010.07.031 · Cited by 98
Development and validation of a risk score to predict early mortality in recipients of implantable cardioverter-defibrillators
Kramer, D. B., Friedman, P. A., Kallinen, L. M., Morrison, T. B., Crusan, D. J., Hodge, D. O., Reynolds, M. R., & Hauser, R. G. (2011) · Heart Rhythm · doi:10.1016/j.hrthm.2011.08.031 · Cited by 94
Canadian Cardiovascular Society/Canadian Heart Rhythm Society 2016 Implantable Cardioverter-Defibrillator Guidelines
Bennett, M. T., Parkash, R., Nery, P. B., Sénéchal, M., Mondesert, B. A., BIRNIE, D. H., Sterns, L. D., Rinne, C., Exner, D. V., Philippon, F., et al. (2016) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2016.09.009 · Cited by 102
Catheter Ablation of Ventricular Tachycardia in Structural Heart Disease
Dukkipati, S. R., Koruth, J. S., Choudry, S., Miller, M. A., Whang, W., & Reddy, V. Y. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.10.030 · Cited by 103
Predictive Score for Identifying Survival and Recurrence Risk Profiles in Patients Undergoing Ventricular Tachycardia Ablation
Vergara, P., Tzou, W. S., Tung, R. H., Brombin, C., Nonis, A., Vaseghi, M., Frankel, D. S., Biase, L. D., Tedrow, U. B., Mathuria, N. S., et al. (2018) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.118.006730 · Cited by 99
Practical compendium of antiarrhythmic drugs: a clinical consensus statement of the European Heart Rhythm Association of the European Society of Cardiology
Merino, J. L., Tamargo, J. L., Blomström‐Lundqvist, C., Boriani, G., Crijns, H. J. G. M., Dobrev, D., Goette, A., Hohnloser, S. H., Naccarelli, G. V., Reiffel, J. A., et al. (2025) · EP Europace · doi:10.1093/europace/euaf076 · Cited by 112
Sudden Cardiac Death Unresponsive to Implantable Defibrillator Therapy: An Urgent Target for Clinicians, Industry and Government
Anderson, K. P. (2005) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-005-4547-9 · Cited by 96
Consensus statement of the European Heart Rhythm Association: updated recommendations for driving by patients with implantable cardioverter defibrillators
Vijgen, J. M., Botto, G., Camm, J. A., Höijer, C. J., Jung, W., Heuzey, J. L., Lubiński, A., Norekvål, T. M., Santomauro, M., Schalij, M. J., et al. (2009) · EP Europace · doi:10.1093/europace/eup112 · Cited by 94
Leitlinien zur Implantation von Defibrillatoren
Hohnloser, S. H., Andresen, D., Block, M. S., Breithardt, G., Jung, W., Klein, H. H., Kuck, K. H., Lüderitz, B., & Steinbeck, G. (2001) · Steinkopff eBooks · doi:10.1007/978-3-642-57631-7_8 · Cited by 96
What evidence do we have to replace in-hospital implantable cardioverter defibrillator follow-up?
Brugada, P. (2006) · Clinical Research in Cardiology · doi:10.1007/s00392-006-1302-x · Cited by 94
The ICD for Primary Prevention in Patients With Inherited Cardiac Diseases
Nordkamp, L. R. A. O., Wilde, A. A. M., Tijssen, J. G. P., Knops, R. E., van Dessel, P. F. H. M., & de Groot, J. R. (2012) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.112.975268 · Cited by 94
Leitlinien zur Implantation von Defibrillatoren
Jung, W., Andresen, D., Block, M. S., Böcker, D., Hohnloser, S. H., Kück, K., & Sperzel, J. (2006) · Clinical Research in Cardiology · doi:10.1007/s00392-006-0475-7 · Cited by 95
Implantable Cardiac Device Procedures in Older Patients
Swindle, J. P., Rich, M. W., McCann, P., Burroughs, T. E., & Hauptman, P. J. (2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2010.30 · Cited by 96
Amiodarone-Induced Thyrotoxicosis Is a Predictor of Adverse Cardiovascular Outcome
Yiu, K., Jim, M., Siu, C., Lee, C., Yuen, M. M. A., Mok, M. M. Y., Shea, Y.-F., Fan, K., Tse, H., & Chow, W. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1907 · Cited by 96
Risk stratification in surgically repaired tetralogy of Fallot
Khairy, P., Dore, A., Poirier, N. C., Marcotte, F., Ibrahim, R., Mongeon, F., & Mercier, L. (2009) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.09.38 · Cited by 95
The Prevalence, Correlates, and Impact on Cardiac Mortality of Right Ventricular Dysfunction in Nonischemic Cardiomyopathy
Pueschner, A., Chattranukulchai, P., Heitner, J. F., Shah, D. J., Hayes, B. D., Rehwald, W. G., Parker, M. A., Kim, H. W., Judd, R. M., Kim, R. J., et al. (2017) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2017.06.013 · Cited by 95
Use of Cardiac Resynchronization Therapy in Patients Hospitalized With Heart Failure
Piccini, J. P., Hernandez, A. F., Dai, D., Thomas, K. L., Lewis, W. R., Yancy, C. W., Peterson, E. D., & Fonarow, G. C. (2008) · Circulation · doi:10.1161/circulationaha.108.773838 · Cited by 94
Frequency and Determinants of Implantable Cardioverter Defibrillator Deployment Among Primary Prevention Candidates With Subsequent Sudden Cardiac Arrest in the Community
Narayanan, K., Reinier, K., Uy‐Evanado, A., Teodorescu, C., Chugh, H. S., Marijon, É., Gunson, K., Jui, J., & Chugh, S. S. (2013) · Circulation · doi:10.1161/circulationaha.113.002539 · Cited by 94
Respiratory rate predicts outcome after acute myocardial infarction: a prospective cohort study
Barthel, P., Wensel, R., Bauer, A., Muller, A., Wolf, P., Ulm, K., Huster, K. M., Francis, D. P., Malik, M., & Schmidt, G. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs420 · Cited by 94
Patient Perceptions, Physician Communication, and the Implantable Cardioverter-Defibrillator
Hauptman, P. J., Chibnall, J. T., Guild, C., & Armbrecht, E. S. (2013) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.3171 · Cited by 94
European Heart Rhythm Association/Heart Failure Association joint consensus document on arrhythmias in heart failure, endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm Society
Lip, G. Y. H., Heinzel, F. R., Gaïta, F., González‐Juanatey, J. R., Heuzey, J. Y. L., Potpara, T., Svendsen, J. H., Vos, M. A., Anker, S. D., Coats, A. J. S., et al. (2015) · EP Europace · doi:10.1093/europace/euv191 · Cited by 99
The fractal heart — embracing mathematics in the cardiology clinic
Captur, G., Karperien, A., Hughes, A. D., Francis, D. P., & Moon, J. (2016) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2016.161 · Cited by 94
Impact of Age and Medical Comorbidity on the Effectiveness of Implantable Cardioverter-Defibrillators for Primary Prevention
Chan, P. S., Nallamothu, B. K., Spertus, J. A., Masoudi, F. A., Bartone, C. L., Kereiakes, D. J., & Chow, T. (2009) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.108.807123 · Cited by 94
Catheter Ablation for Ventricular Tachycardia in Patients with an Implantable Cardioverter Defibrillator (CALYPSO) Pilot Trial
Al‐Khatib, S. M., Daubert, J. P., Anstrom, K. J., Daoud, E. G., Gonzalez, M. D., Saba, S., JACKSON, K. P., Reece, T. L., Gu, J., Pokorney, S. D., et al. (2014) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.12567 · Cited by 93
Self-citation
Long-Term Outcomes of Implantable Cardioverter-Defibrillator Therapy in the SCD-HeFT
Poole, J. E., Olshansky, B., Mark, D. B., Anderson, J., Johnson, G. W., Hellkamp, A. S., Davidson-Ray, L. D., Fishbein, D. P., Boineau, R., Anstrom, K. J., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.05.061 · Cited by 91
Self-citation
Timing of the Most Recent Device Procedure Influences the Clinical Outcome of Lead-Associated Endocarditis
Greenspon, A. J., Prutkin, J. M., Sohail, M. R., Vikram, H. R., Baddour, L. M., Danik, S. B., Peacock, J. E., Falces, C., Miró, J. M., Blank, E., et al. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.11.011 · Cited by 92
Early identification of risk factors for sudden cardiac death
Chugh, S. S. (2010) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2010.52 · Cited by 95
Post-cardiac arrest syndrome: Epidemiology, pathophysiology, treatment, and prognostication: A Scientific Statement from the International Liaison Committee on Resuscitation; the American Heart Association Emergency Cardiovascular Care Committee; the Council on Cardiovascular Surgery and Anesthesia; the Council on Cardiopulmonary, Perioperative, and Critical Care; the Council on Clinical Cardiology; the Council on Stroke (Part 1)
Nolan, J. P., Neumar, R. W., Adrie, C., Aibiki, M., Berg, R. A., Bbttiger, B. W., Callaway, C. W., Clark, R. S. B., Geocadin, R. G., Jauch, E. C., et al. (2009) · International Emergency Nursing · doi:10.1016/j.ienj.2009.01.001 · Cited by 93
American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society Scientific Statement on Noninvasive Risk Stratification Techniques for Identifying Patients at Risk for Sudden Cardiac Death
Goldberger, J. J., CAIN, M. E., Hohnloser, S. H., Kadish, A. H., Knight, B. P., Lauer, M. S., Maron, B. J., Page, R. L., PASSMAN, R. S., Siscovick, D. S., et al. (2008) · Heart Rhythm · doi:10.1016/j.hrthm.2008.05.031 · Cited by 93
Catheter ablation of ventricular tachycardia in ischaemic and non-ischaemic cardiomyopathy: where are we today? A clinical review
Wißner, E., Stevenson, W. G., & Kück, K. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs007 · Cited by 94
2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias
Cronin, E. M., Bogun, F. M., Maury, P., Peichl, P., Chen, M., Namboodiri, N., Aguinaga, L., Leite, L. R., Al‐Khatib, S. M., Anter, E., et al. (2020) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-019-00663-3 · Cited by 95
Guidelines for Secondary Prevention of Myocardial Infarction (JCS 2011)
JCS Joint Working Group (2012) · Circulation Journal · doi:10.1253/circj.cj-66-0053 · Cited by 92
Effective Management of ICD Patient Psychosocial Issues and Patient Critical Events
Sears, S. F., Matchett, M., & CONTI, J. B. (2009) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2009.01526.x · Cited by 92
A Novel Two-Dimensional Echocardiographic Image Analysis System Using Artificial Intelligence-Learned Pattern Recognition for Rapid Automated Ejection Fraction
Cannesson, M. P., Tanabe, M., Suffoletto, M. S., McNamara, D. M., Madan, S., Lacomis, J. M., & Gorcsan, J. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.08.045 · Cited by 93
Changes in Follow-Up Left Ventricular Ejection Fraction Associated With Outcomes in Primary Prevention Implantable Cardioverter-Defibrillator and Cardiac Resynchronization Therapy Device Recipients
Zhang, Y., Güallar, E., Blasco‐Colmenares, E., Butcher, B., Norgard, S., Nauffal, V. D., Marine, J. E., ELDADAH, Z. A., Dickfeld, T. M., Ellenbogen, K. A., et al. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.05.057 · Cited by 91
Rhythm Control in Heart Failure Patients With Atrial Fibrillation
Trulock, K. M., Narayan, S. M., & Piccini, J. P. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.06.1169 · Cited by 92
Meta-Analysis of Mortality in Dialysis Patients With an Implantable Cardioverter Defibrillator
Sakhuja, R., Keebler, M., Lai, T., McLaughlin-Gavin, C., Thakur, R. K., & Bhatt, D. L. (2009) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2008.11.014 · Cited by 90
Nonadherence to treatment protocol in published randomised controlled trials: a review
Dodd, S. R., White, I. R., & Williamson, P. R. (2012) · Trials · doi:10.1186/1745-6215-13-84 · Cited by 89
Survival Benefit of Implantable Cardioverter-Defibrillators in Left Ventricular Assist Device–Supported Heart Failure Patients
Refaat, M. M., Tanaka, T. D., Kormos, R. L., McNamara, D. M., Teuteberg, J. J., Winowich, S., London, B., & Simon, M. A. M. (2011) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2011.10.020 · Cited by 91
A genetic framework for improving arrhythmia therapy
Knollmann, B. C., & Roden, D. M. (2008) · Nature · doi:10.1038/nature06799 · Cited by 89
Review of the ICD Registry's Third Year, Expansion to include Lead Data and Pediatric ICD Procedures, and Role for Measuring Performance
Hammill, S. C., Kremers, M. S., Kadish, A. H., Stevenson, L. W., Heidenreich, P. A., Lindsay, B. D., Mirro, M. J., Radford, M. J., McKay, C., Wang, Y., et al. (2009) · Heart Rhythm · doi:10.1016/j.hrthm.2009.07.015 · Cited by 91
Pharmacokinetics of Amiodarone in hyperlipidemic and simulated high fat‐meal rat models
Shayeganpour, A., Jun, A. S., & Brocks, D. R. (2005) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.457 · Cited by 91
ACCF/AHA/ACP/HFSA/ISHLT 2010 Clinical Competence Statement on Management of Patients With Advanced Heart Failure and Cardiac Transplant
Francis, G. S., Greenberg, B., Hsu, D. T., Jaski, B. E., Jessup, M. L., LeWinter, M. M., Pagani, F. D., Piña, I. L., Semigran, M. J., Walsh, M. N., et al. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.04.014 · Cited by 91
Matching the Market for Heart Transplantation
Hsich, E. (2016) · Circulation Heart Failure · doi:10.1161/circheartfailure.115.002679 · Cited by 91
Non-ischaemic cardiomyopathy, sudden death and implantable defibrillators: a review and meta-analysis
Beggs, S. A. S., Jhund, P. S., Jackson, C. E., McMurray, J. J. V., & Gardner, R. S. (2017) · Heart · doi:10.1136/heartjnl-2016-310850 · Cited by 90
Sudden Death in Patients With Cardiac Implantable Electronic Devices
Tseng, Z. H., Hayward, R. M., Clark, N. M., Mulvanny, C. G., Colburn, B., Ursell, P. C., Olgin, J. E., Hart, A. P., & Moffatt, E. (2015) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2015.2641 · Cited by 92
Amiodarone: an effective antiarrhythmic drug with unusual side effects
ERVEN, L. V., & Schalij, M. J. (2010) · Heart · doi:10.1136/hrt.2008.152652 · Cited by 91
Canadian Cardiovascular Society Consensus Conference guidelines on heart failure, update 2009: Diagnosis and management of right-sided heart failure, myocarditis, device therapy and recent important clinical trials
Howlett, J. G., McKelvie, R. S., Arnold, J. M. O., Costigan, J., Dorian, P., Ducharme, A., Estrella-Holder, E., Ezekowitz, J. A., Giannetti, N., Haddad, H. A., et al. (2009) · Canadian Journal of Cardiology · doi:10.1016/s0828-282x(09)70477-5 · Cited by 90
Increased mortality with left ventricular systolic dysfunction and heart failure in adults with myotonic dystrophy type 1
Bhakta, D., Groh, M. R., Shen, C., Pascuzzi, R. M., & Groh, W. J. (2010) · American Heart Journal · doi:10.1016/j.ahj.2010.07.032 · Cited by 89
Cardiac Applications of 123I-mIBG Imaging
Chirumamilla, A. P., & Travin, M. I. (2011) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2011.04.001 · Cited by 89
Increased Left Ventricular Mass as a Predictor of Sudden Cardiac Death
Stevens, S. M., Reinier, K., & Chugh, S. S. (2013) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.112.974931 · Cited by 89
Evolution of risk stratification and sudden death prevention in hypertrophic cardiomyopathy: Twenty years with the implantable cardioverter-defibrillator
Maron, B. J., Rowin, E. J., & Maron, M. S. (2021) · Heart Rhythm · doi:10.1016/j.hrthm.2021.01.019 · Cited by 89
Performance and Safety of the Extravascular Implantable Cardioverter Defibrillator Through Long-Term Follow-Up: Final Results From the Pivotal Study
Friedman, P. A., MURGATROYD, F. D., Boersma, L. V. A., Manlucu, J., Knight, B. P., Clémenty, N., Leclercq, C., Amin, A. K., Merkely, B. P., Birgersdotter-Green, U. M., et al. (2024) · Circulation · doi:10.1161/circulationaha.124.071795 · Cited by 89
Evidence regarding clinical use of microvolt T-wave alternans
Hohnloser, S. H., Ikeda, T., & Cohen, R. J. (2008) · Heart Rhythm · doi:10.1016/j.hrthm.2008.10.011 · Cited by 89
Mitochondrial dysfunction causing cardiac sodium channel downregulation in cardiomyopathy
Liu, M., Gu, L., Sulkin, M. S., Liu, H., Jeong, E.-M., Greener, I. D., Xie, A., Efimov, I. R., & Dudley, S. C. (2012) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2012.10.011 · Cited by 90
Advances in Echocardiographic Imaging in Heart Failure With Reduced and Preserved Ejection Fraction
Omar, A. M. S., Bansal, M., & Sengupta, P. P. (2016) · Circulation Research · doi:10.1161/circresaha.116.309128 · Cited by 91
Syncope
Saklani, P., Krahn, A. D., & Klein, G. J. (2013) · Circulation · doi:10.1161/circulationaha.112.138396 · Cited by 91
Prognostic Value and Temporal Behavior of the Planar QRS-T Angle in Patients With Nonischemic Cardiomyopathy
Pavri, B. B., Hillis, M. B., Subačius, H., Brumberg, G. E., Schaechter, A., Levine, J. H., & Kadish, A. (2008) · Circulation · doi:10.1161/circulationaha.107.733451 · Cited by 88
2020 Clinical practice guidelines for Chronic heart failure
Russian Society of Cardiology (2020) · Russian Journal of Cardiology · doi:10.15829/29/1560-4071-2020-4083 · Cited by 88
Ventricular Tachycardia Ablation Remains Treatment of Last Resort in Structural Heart Disease: Argument for Earlier Intervention
Frankel, D. S., Mountantonakis, S., Robinson, M., Zado, E. S., Callans, D. J., & Marchlinski, F. E. (2011) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2011.02081.x · Cited by 88
The diagnosis and management of ventricular arrhythmias
Roberts‐Thomson, K. C., Lau, D. H., & Sanders, P. (2011) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2011.15 · Cited by 91
Implantable Defibrillators and Prevention of Sudden Death in Hypertrophic Cardiomyopathy
Maron, B. J., & Spirito, P. (2008) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2008.01147.x · Cited by 89
Electrocardiographic versus echocardiographic left ventricular hypertrophy and sudden cardiac arrest in the community
Narayanan, K., Reinier, K., Teodorescu, C., Uy‐Evanado, A., Chugh, H. S., Gunson, K., Jui, J., & Chugh, S. S. (2014) · Heart Rhythm · doi:10.1016/j.hrthm.2014.03.023 · Cited by 88
Comparison of Medical Therapy Dosing in Outpatients Cared for in Cardiology Practices With Heart Failure and Reduced Ejection Fraction With and Without Device Therapy
Heywood, J. T., Fonarow, G. C., Yancy, C. W., Albert, N. M., Curtis, A. B., Gheorghiade, M., Inge, P. J., McBride, M. L., Mehra, M. R., O’Connor, C. M., et al. (2010) · Circulation Heart Failure · doi:10.1161/circheartfailure.109.912683 · Cited by 88
Post-cardiac arrest syndrome: Epidemiology, pathophysiology, treatment, and prognostication: A Scientific Statement from the International Liaison Committee on Resuscitation; the American Heart Association Emergency Cardiovascular Care Committee; the Council on Cardiovascular Surgery and Anesthesia; the Council on Cardiopulmonary, Perioperative, and Critical Care; the Council on Clinical Cardiology; the Council on Stroke (Part II)
Nolan, J. P., Neumar, R. W., Adrie, C., Aibiki, M., Berg, R. A., Bbttiger, B. W., Callaway, C. W., Clark, R. S. B., Geocadin, R. G., Jauch, E. C., et al. (2009) · International Emergency Nursing · doi:10.1016/j.ienj.2009.07.001 · Cited by 90
Patient and Cardiologist Perceptions on Decision Making for Implantable Cardioverter‐Defibrillators: A Qualitative Study
Matlock, D. D., Nowels, C. T., Masoudi, F. A., Sauer, W. H., Bekelman, D. B., Main, D. S., & Kutner, J. S. (2011) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2011.03237.x · Cited by 87
Sudden Cardiac Death: Epidemiology, Mechanisms, and Therapy
Turakhia, M. P., & Tseng, Z. H. (2007) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2007.05.002 · Cited by 88
Cost-effectiveness of heart failure therapies
Rohde, L. E. P., Bertoldi, E. G., Goldraich, L. A., & Polanczyk, C. A. (2013) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2013.60 · Cited by 86
A Randomized Study to Compare Ramp Versus Burst Antitachycardia Pacing Therapies to Treat Fast Ventricular Tachyarrhythmias in Patients With Implantable Cardioverter Defibrillators
Gulizia, M. M., Piraino, L., Scherillo, M., Puntrello, C., Vasco, C., Scianaro, M. C., Mascia, F., Pensabene, O., Giglia, S., Chiarandà, G., et al. (2009) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.108.804211 · Cited by 87
Gender and outcomes after primary prevention implantable cardioverter-defibrillator implantation: Findings from the National Cardiovascular Data Registry (NCDR)
Russo, A. M., Daugherty, S. L., Masoudi, F. A., Wang, Y., Curtis, J. P., & Lampert, R. J. (2015) · American Heart Journal · doi:10.1016/j.ahj.2015.02.025 · Cited by 86
Progression of Myocardial Fibrosis in Nonischemic DCM and Association With Mortality and Heart Failure Outcomes
Mandawat, A., Chattranukulchai, P., Mandawat, A., Blood, A. J., Ambati, S., Hayes, B. D., Rehwald, W. G., Kim, H. W., Heitner, J. F., Shah, D. J., et al. (2021) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2020.11.006 · Cited by 86
Prolonged QRS duration on the resting ECG is associated with sudden death risk in coronary disease, independent of prolonged ventricular repolarization
Teodorescu, C., Reinier, K., Uy‐Evanado, A., Navarro, J., Mariani, R., Gunson, K., Jui, J., & Chugh, S. S. (2011) · Heart Rhythm · doi:10.1016/j.hrthm.2011.06.011 · Cited by 86
Primary Prevention with Defibrillator Therapy in Women: Results from the Sudden Cardiac Death in Heart Failure Trial
Russo, A. M., Poole, J. E., Mark, D. B., Anderson, J., Hellkamp, A. S., Lee, K. L., Johnson, G. W., DOMANSKI, M. J., & Bardy, G. H. (2008) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2008.01129.x · Cited by 86
Self-citation
Implantable cardioverter-defibrillator deactivation at the end of life: A physician survey
Kelley, A. S., Reid, M. C., Miller, D. H., Fins, J. J., & Lachs, M. S. (2009) · American Heart Journal · doi:10.1016/j.ahj.2008.12.011 · Cited by 86
Implantable Cardioverter Defibrillator Therapy in Adults With Congenital Heart Disease
Koyak, Z., de Groot, J. R., Gelder, I. C. V., Bouma, B. J., van Dessel, P. F. H. M., Budts, W., van Erven, L., van Dijk, A. P. J., Wilde, A. A. M., Pieper, P. G., et al. (2011) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.111.966754 · Cited by 85
The prognosis of implantable defibrillator patients treated with cardiac resynchronization therapy: comorbidity burden as predictor of mortality
Theuns, D. A. M. J., Schaer, B. A., Soliman, O. I. I., Altmann, D., Sticherling, C., Geleijnse, M. L., Osswald, S., & Jordaens, L. J. L. M. (2010) · EP Europace · doi:10.1093/europace/euq328 · Cited by 86
Impact of mineralocorticoid receptor antagonists on the risk of sudden cardiac death in patients with heart failure and left-ventricular systolic dysfunction: an individual patient-level meta-analysis of three randomized-controlled trials
Rosselló, X., Ariti, C. A., Pocock, S., Ferreira, J. P., Girerd, N., McMurray, J. J. V., van Veldhuisen, D. J., Pitt, B., & Zannad, F. M. (2018) · Clinical Research in Cardiology · doi:10.1007/s00392-018-1378-0 · Cited by 89
Amiodarone-Induced Thyrotoxicosis
Conen, D., Melly, L., Kaufmann, C. C., Bilz, S., Ammann, P., Schaer, B. A., Sticherling, C., Müller-Stich, B. P., & Osswald, S. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.02.054 · Cited by 87
Review of the Registry’s First Year, Data Collected, and Future Plans
Hammill, S. C., Stevenson, L. W., Kadish, A. H., Kremers, M. S., Heidenreich, P. A., Lindsay, B. D., Mirro, M. J., Radford, M. J., Wang, Y., Lang, C. M., et al. (2007) · Heart Rhythm · doi:10.1016/j.hrthm.2007.07.021 · Cited by 85
Increased left ventricular mass and decreased left ventricular systolic function have independent pathways to ventricular arrhythmogenesis in coronary artery disease
Reinier, K., Dervan, C., Singh, T., Uy‐Evanado, A., Lai, S., Gunson, K., Jui, J., & Chugh, S. S. (2011) · Heart Rhythm · doi:10.1016/j.hrthm.2011.02.037 · Cited by 84
Risk stratification of sudden cardiac death: a review
Tfelt‐Hansen, J., Garcia, R., Albert, C. M., Merino, J. L., Krahn, A. D., Marijon, É., Basso, C., Wilde, A. A. M., & Haugaa, K. H. (2023) · EP Europace · doi:10.1093/europace/euad203 · Cited by 84

Authors: Bardy, G. H., Lee, K. L., Mark, D. B., Poole, J. E., Packer, D. L., Boineau, R., Domanski, M., Troutman, C., Anderson, J., Johnson, G., McNulty, S. E., Clapp-Channing, N., Davidson-Ray, L. D., Fraulo, E. S., Fishbein, D. P., Luceri, R. M., & Ip, J. H.
Affiliations: The Seattle Institute for Cardiac Research (US)
Duke University (US)
University of Washington (US)
Mayo Clinic (US)
National Heart, Lung, and Blood Institute (US)
ORCID: Lee, Kerry L.
Mark, Daniel B.
Poole, Jeanne E.
Packer, Douglas L.
Boineau, Robin
Davidson-Ray, Linda D.
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 2005-01-20
Volume: 352
Issue: 3
Pages: 225-237
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejmoa043399
OpenAlex: W2075175982
Semantic Scholar: cf04075b17dbae3fc6bc9a3a2f9673f9fad192ea
Cited by: 6,552
References: 20
Citations by year: 2026: 126 · 2025: 170 · 2024: 173 · 2023: 186 · 2022: 231 · 2021: 236 · 2020: 261 · 2019: 285 · 2018: 287 · 2017: 394 · 2016: 326 · 2015: 355 · 2014: 335 · 2013: 369 · 2012: 376
FWCI: 292.60
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: New England Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
Funders: National Heart, Lung, and Blood Institute (UO1 HL55297, UO1 HL55496, UO1 HL55766, U01HL055297, U01HL055766, U01HL055496)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac pacing and defibrillation studies
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Health and Mental Health
Keywords: amiodarone, implantable cardioverter-defibrillator, congestive heart failure, sudden cardiac death, mortality, left ventricular ejection fraction, NYHA functional class, antiarrhythmic therapy
MeSH terms: Aged, Amiodarone, Anti-Arrhythmia Agents, Cause of Death, Female, Heart Failure, Humans, Male, Middle Aged, Risk, Stroke Volume, Survival Analysis, Death, Sudden, Cardiac, Defibrillators, Implantable, Cross-Over Studies

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Amiodarone or an Implantable Cardioverter–Defibrillator for Congestive Heart Failure

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks